No long-term benefits of supplementation with arabinogalactan on serum lipids and glucose

Journal of the American Dietetic Association

Volumn 104, Issue 4, 2004, Pages 636-639

  Marett, Rebecca ^a,b   Slavin, Joanne L ^a,c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b St Francis Regional Medical Center   (United States)

^c Dept of Food Science and Nutrition ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; ARABINOGALACTAN; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY FIBER; DOUBLE BLIND PROCEDURE; FEMALE; FOOD INTAKE; GASTROINTESTINAL SYMPTOM; GLUCOSE ASSAY; GLUCOSE BLOOD LEVEL; HEALTH SURVEY; HUMAN; INSULIN BLOOD LEVEL; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; MALE; NORMAL HUMAN; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ADULT; APOLIPOPROTEINS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY WEIGHT; CHOLESTEROL; CHOLESTEROL, HDL; DIET RECORDS; DIETARY FIBER; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; GALACTANS; HUMANS; INSULIN; LIPIDS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; TRIGLYCERIDES;

LARIX; LARIX LARICINA;

EID: 1842579956     PISSN: 00028223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jada.2004.01.017     Document Type: Article

References (11)

1. Kelly G.S. Larch arabinogalactan Clinical relevance of a novel immune-enhancing polysaccharide. Altern Med Rev. 4:1999;96-103.
2. Clarke A.E., Anderson R.L., Stone B.A. Form and function of arabinogalactans and arabinogalactan-proteins. Phytochemistry. 18:1979;521-540.
3. Trumbo P., Schlicker S., Yates A.A., Poos M. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids. J Am Diet Assoc. 102:2002;1621-1631.
4. Marlett J.A., McBurne M.I., Slavin J.L. Position of the American Dietetic Association Health implications of dietary fiber. J Am Diet Assoc. 102:2002;993-1000.
5. Knopp R.H., Superko R., Davidson M., Insull W., Dujovne C.A., Kwiterovich P.O., Zavoral J.H., Graham K., O'Connor R.R., Edelman D.A. Long-term blood cholesterol-lowering effects of a dietary fiber supplement. Am J Prev Med. 17:1999;18-23.
6. Behall K.M. Effect of soluble fibers on plasma lipids, glucose tolerance and mineral balance. Adv Exp Med Biol. 270:1990;7-16.
7. Strocchi A., Levitt M.D. Measurement of starch absorption in humans. Can J Physiol Pharmacol. 69:1991;108-110.
8. Gallaher D.D., Gallaher C.M., Mahrt G.J., Carr T.P., Hollinghead C.H., Hesslink R., Wise J. A glucomannan and chitosan fiber supplement decreases plasma cholesterol and increases cholesterol excretion in overweight normocholesterolemic humans. J Am Coll Nutr. 21:2002;428-433.
9. Brown L., Rosner B., Willett W.W., Sacks F.M. Cholesterol-lowering effects of dietary fiber A meta-analysis. Am J Clin Nutr. 69:1999;30-42.
10. Jenkins D.J.A., Kendall C.W.C., Vuksan V., Vidgen E., Parker T., Faulkner D., Mehling C.C., Garsetti M., Testolin G., Cunnane S.C., Ryan M.A., Corey P.N. Soluble fiber intake at a dose approved by the US Food and Drug Administration for a claim of health benefits Serum lipid risk factors for cardiovascular disease assessed in a randomized controlled crossover trial. Am J Clin Nutr. 75:2002;834-839.
11. Dietary Reference Intakes for Energy, Carbohydrates, Fiber, Fat, Protein and Amino Acids (Macronutrients) 2002. Food and Nutrition Board, Institute of Medicine. 2002;The National Acadamies Press, Washington, DC.